Framing Biotech Benefits Matters When Introducing Gene-Edited Orange Juice to Consumers

A study from the University of Florida examined how information framing influences consumer willingness to pay for biotechnology-derived foods. Researchers assessed how consumers valued bioengineered orange juice compared with Non-GMO Project Verified alternatives. They found that explaining how gene editing and bioengineering could help protect citrus trees from citrus greening, a disease devastating Florida's groves, reduced consumers' reluctance to pay for biotech-derived juice. The findings highlight how connecting biotechnology to real-world agricultural challenges can shape consumer perceptions.

The experiment revealed that making scientific concepts easy to understand is helpful, but explaining why the technology is needed matters even more. Without background information, shoppers expected bioengineered orange juice to cost $1.65 less per bottle than Non-GMO Project Verified juice. Plain-language explanations helped participants better understand the differences between gene editing and traditional genetic modification, but clarity alone did not increase what they were willing to pay. When researchers explained how these technologies could help protect citrus trees from citrus greening, a disease devastating Florida's groves, the price penalty fell to just $0.42 per bottle.

These findings offer a practical roadmap for food producers, scientists, and agricultural educators looking to build public trust in modern crop breeding. While transparent messaging reduces buyer hesitation, it does not completely eliminate the market preference for non-GMO choices. To successfully introduce disease-resistant crops, industry leaders must combine clear technical explanations with strong, problem-solving narratives that show how biotechnology directly protects the food supply.

Read the full study in the SSRN Electronic Journal to learn more.